fluoxymesterone has been researched along with Osteosarcoma in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chang, W; Chapman, MS; Finn, PD; Hong, MH; López, FJ; Marschke, KB; Miner, JN; Negro-Vilar, A; Rosen, J; Schrader, W; Turner, R; van Oeveren, A; Viveros, H; Zhi, L | 1 |
1 other study(ies) available for fluoxymesterone and Osteosarcoma
Article | Year |
---|---|
An orally active selective androgen receptor modulator is efficacious on bone, muscle, and sex function with reduced impact on prostate.
Topics: Administration, Oral; Aminoquinolines; Animals; Antineoplastic Agents, Hormonal; Biomechanical Phenomena; Cell Line, Tumor; Copulation; Fluoxymesterone; Humans; Lumbar Vertebrae; Male; Muscle, Skeletal; Orchiectomy; Osteosarcoma; Prostate; Prostatic Neoplasms; Quinolones; Rats; Rats, Sprague-Dawley; Receptors, Androgen; Spodoptera | 2007 |